To cite this paper use one of the standards below:
The prolonged use of NSAIDs or SAIDs in the treatment of certain pathologies can lead to numerous side effects. Therefore, the goal of chemists is to discover new molecules with effective results and fewer side effects. Cannabidiol has been explored as a therapeutic agent for various disorders, demonstrating anti-inflammatory, immunomodulatory, and analgesic properties. Female Swiss Webster mice (28-32 g, n = 6-8) were injected with carrageenan for evaluate the anti-inflammatory effects and treated orally with the analogue (PQM-290) at doses of 1, 3 and 10 μmol/kg. One hour later, they received an injection of carrageenan (0.5%, 1 mL) or saline (NaCl 0.9%) into the SAP (subcutaneous air pouch). After 24 hours, the animals were euthanized, and the SAP exudate was collected for leukocyte counts and cytokine measurement. Results are presented as mean ± SD. Statistical analysis was performed by ANOVA followed by Tukey's test (*p<0.05). The protocol for the use of animals was approved by CEUA/UFRJ and received number 35/19. Carrageenan injected in SAP led to an increase in cellularity (129±19.5x10³cells/μL) when compared to the saline-injected group (3.12±1.6x10³cells/μL). The group of animals treated with PQM significantly reduced leukocyte migration, as follows: PQM-290 1μmol/kg: 83.6±15*x10³cells/μL; 3μmol/kg: 129.9±40.8 x10³cells/μL; 10μmol/kg: 98.8±14.4x10³cells/μL. Dexamethasone (9 μmol/kg) treatment also resulted in a reduction: 53.5±18.8*x10³cells/μL. Carrageenan injection into SAP resulted in an increase in IL-6 levels (965.4±233 pg/mL) when compared to the vehicle-treated group (53±21.5 pg/mL). The pre-treatment with dexamethasone did significantly reduced IL6 production (344.4±203*pg/mL). All three doses of PQM-290 also demonstrated significant effect: 1μmol/kg: 425.1±105.2*pg/mL; 3μmol/kg: 185.5±117.1*pg/mL; 10μmol/kg: 33.5±21*pg/mL. Results suggest that cannabidiol-based molecule has anti-inflammatory potencial reducing some parameters of acute inflammation.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper